Forward Look Sexual Health in Adolescent and Young Adult Survivors Cancer survivors diagnosed early in life may have unanswered questions about their sexual health. by Lindsey Konkel Get Involved Bringing Joy to the Pediatric Ward Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients. by Bradley Jones Rethinking Access to Disability Benefits Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments. by Jen Tota McGivney Understanding How Radiation Causes Cancer Researchers are investigating who is at greatest risk for radiation-induced cancers. by Kate Yandell Chemobrain: It’s Not Your Imagination Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021. by Marci A. Landsmann From the Editor-in-Chief Cancer in Adolescents and Young Adults Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them. by William G. Nelson, MD, PhD Sound Advice Your Questions, Our Answers Maintaining relationships through cancer, feeling unappreciated as a caregiver, and finding information that's relevant to young people with cancer. Colorectal Cancer Screenings at Home Stool-based tests could increase access to colorectal cancer screening. by Jen Tota McGivney When Young Adults Need Care For adolescents and young adults who have been diagnosed with cancer, caregivers can play an influential—but often overlooked—role in providing help and support. by Carly Flumer Getting Serious About Depression Cancer survivors have higher rates of depression than the general population, but many don’t know help is available. by Cameron Walker next Cancer Talk Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks The Individual Sphere of Influence Can discussion of health inequities lead to actionable change? by Marci A. Landsmann A Treatment That Came Just in Time Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma. by Laurie Adami More Posts